The respiratory syncytial virus (RSV) season, typically starting in the fall and peaking in winter, is upon us. However, this season comes with certain alerts that parents should take note of.
On October 23, 2023, the Centers for Disease Control and Prevention (CDC) issued a Health Advisory to provide guidance to healthcare professionals to help protect infants from RSV in response to the limited supply of nirsevimab, a monoclonal antibody immunization product recommended to prevent RSV-related respiratory disease in infants.
The CDC’s guidance advises prioritizing the use of nirsevimab 100mg doses for infants at the highest risk of severe RSV disease, which are infants aged 6 months and younger, as well as infants with underlying or preexisting conditions that place them in the high-risk category. It is also recommended that clinicians avoid using the 50mg dose for infants weighing more than 11 pounds (5 kilograms) to conserve the supply for lighter infants. Additionally, providers are advised to suspend the use of nirsevimab in children aged 8-19 months who are eligible for palivizumab during the 2023-2024 RSV season.
What does this mean for parents?
1. Be Informed: Stay informed about these limitations and keep a close eye on your infant’s health for any signs or symptoms of RSV.
2. Preventative Measures: Continue practicing preventive measures to reduce the risk of contracting and spreading RSV and other respiratory illnesses. These measures include regular handwashing, covering coughs and sneezes, disinfecting frequently touched surfaces, and staying home when sick.
3. Consult Healthcare Providers: Reach out to your child’s healthcare provider to inquire about the availability of nirsevimab for your infant. Discuss possible alternatives and options with them.
For more information, you can visit the following resources provided by the CDC:
– CDC RSV Advisory
– Symptoms and care of RSV
– What parents should know about RSV vaccinations
– RSV Preventive Antibody Immunization Information Statement.
These resources can provide more detailed information and guidance on dealing with RSV during this season.